An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects
Clinical trial NCT02046213 · COMPLETED
Trial details
- NCT number
- NCT02046213
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.